Matthew B. Murphy - 12 Aug 2022 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
General Counsel
Signature
/s/ Matthew B. Murphy
Issuer symbol
NAUT
Transactions as of
12 Aug 2022
Net transactions value
+$28,432
Form type
4
Filing time
16 Aug 2022, 20:19:19 UTC
Previous filing
13 May 2022
Next filing
01 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAUT Common Stock Purchase $7,125 +2,500 +5.7% $2.85 46,640 12 Aug 2022 See Footnote F1
transaction NAUT Common Stock Purchase $21,308 +7,500 +16% $2.84 54,140 15 Aug 2022 See Footnote F1
holding NAUT Common Stock 1,250 12 Aug 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by the Murphy Family Trust. The reporting person is the Trustee of the Murphy Family Trust.
F2 1,250 shares of Common Stock acquired on June 1, 2022 through the Issuer's 2021 Employee Stock Purchase Plan.